Detalhe da pesquisa
1.
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR).
Pediatr Blood Cancer
; 69(11): e29901, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35989458
2.
A phase I study of panobinostat in children with relapsed and refractory hematologic malignancies.
Pediatr Hematol Oncol
; 37(6): 465-474, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32338562
3.
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.
N Engl J Med
; 375(26): 2550-2560, 2016 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28029918
4.
Kaposiform lymphangiomatosis: unifying features of a heterogeneous disorder.
Pediatr Blood Cancer
; 62(5): 901-4, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25307772
5.
Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors.
Pediatr Blood Cancer
; 62(4): 603-10, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25556988
6.
Prolonged Complete Response in a Pediatric Patient With Primary Peripheral T-Cell Lymphoma of the Central Nervous System.
Pediatr Hematol Oncol
; 32(8): 529-34, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26384083
7.
FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement.
Clin Cancer Res
; 29(5): 838-842, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36206041
8.
FDA Approval Summary: Entrectinib for the Treatment of NTRK gene Fusion Solid Tumors.
Clin Cancer Res
; 27(4): 928-932, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32967940
9.
FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid Tumors.
Clin Cancer Res
; 27(17): 4685-4689, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083238
10.
FDA Approval Summary: Pembrolizumab for the First-line Treatment of Patients with MSI-H/dMMR Advanced Unresectable or Metastatic Colorectal Carcinoma.
Clin Cancer Res
; 27(17): 4680-4684, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33846198
11.
FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors.
Clin Cancer Res
; 25(13): 3753-3758, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30787022
12.
Cushing Disease in a patient with Multiple Endocrine Neoplasia type 2B.
J Clin Transl Endocrinol Case Rep
; 4: 1-4, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28435794
13.
FDA Approval Summary: TAS-102.
Clin Cancer Res
; 23(12): 2924-2927, 2017 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28213365
14.
Patterns of thyroid hormone levels in pediatric medullary thyroid carcinoma patients on vandetanib therapy.
Int J Pediatr Endocrinol
; 2015(1): 3, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25972901
15.
Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma.
Clin Cancer Res
; 19(15): 4239-48, 2013 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23766359
16.
The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates.
Cancer Chemother Pharmacol
; 69(1): 247-52, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21706317
17.
(111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents.
J Clin Endocrinol Metab
; 97(2): E207-12, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22162469